Jagriti Upadhyay - Concepedia

Author

Jagriti Upadhyay

Beth Israel Deaconess Medical Center ORCID

Also Known As

A. GAVRIELI, JAGRITI UPADHYAY, Jagriti Upadhyay

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Harvard University VA Boston Healthcare System 424 General Military Hospital Aristotle University of Thessaloniki

About

Jagriti Upadhyay is an author at Beth Israel Deaconess Medical Center specializing in medicine, endocrinology, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	400
2	Endocrinology	4	4	226
3	Diabetes	3	3	181
4	Social Sciences	1	1	50
5	Cellular Physiology	1	1	47

Jagriti Upadhyay

Publications

747

Citations

H-Index

Page 1

	Year	Citations
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps Nishant Dwivedi, Jagriti Upadhyay, Indira Neeli, Arthritis & Rheumatism	2011	122
Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials Nikolaos Perakakis, Alexander Kokkinos, Natia Peradze, Metabolism ObesityMetabolic SyndromeBariatric SurgeryNutritionSleeve Gastrectomy	2019	86
Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study Ayse Sahin-Efe, Jagriti Upadhyay, Byung‐Joon Ko, Metabolism ObesityMetabolic SyndromeLeptin ConcentrationsDiabetes EpidemiologyHealth Policy	2017	75
Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy Athanasios D. Anastasilakis, Dimitrios Koulaxis, Nikoleta Kefala, Metabolism Irisin LevelsCardiovascular DiseaseCardiologyGlaucomaCk-mb Accuracy	2017	69
Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies Olivia M. Farr, Jagriti Upadhyay, Chelsea Rutagengwa, Diabetes Obesity and Metabolism	2019	58
Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross‐over, randomized, double‐blind, controlled inpatient physiology study Dario Tuccinardi, Olivia M. Farr, Jagriti Upadhyay, Diabetes Obesity and Metabolism	2019	51
Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial Olivia M. Farr, Jagriti Upadhyay, Anna Gavrieli, Diabetes NeuropsychologyAffective NeuroscienceBrain CentersPsychopharmacologyAttention	2016	50
Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function Nikolaos Perakakis, Jagriti Upadhyay, Wael Ghaly, Metabolism Reproductive FunctionSignal TransductionDevelopmental BiologyCell DivisionMolecular Regulation	2018	47
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial Dario Tuccinardi, Olivia M. Farr, Jagriti Upadhyay, Diabetes Obesity and Metabolism	2019	47
The Syndrome of Hypoparathyroidism, Deafness, and Renal Anomalies Jagriti Upadhyay, Devin Steenkamp, Jeff M. Milunsky Endocrine Practice UrologyMedicineRenal PathologyParathyroid DiseaseRenal Anomalies	2013	35

Page 1